H.C. Wainwright Starts ProQR Therapeutics N.V. (PRQR) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Deutsche Bank Starts ProQR Therapeutics N.V. (PRQR) at Buy
October 15, 2014 7:10 AM EDTDeutsche Bank initiates coverage on ProQR Therapeutics N.V. (NASDAQ: PRQR) with a Buy rating and a price target of $32.00.
Analyst Alethia Young said, "Cystic fibrosis (CF) drug development is in a renaissance era with rapid progress in the past few years led... More
JMP Securities Starts ProQR Therapeutics N.V. (PRQR) at Market Outperform
October 14, 2014 7:30 AM EDTJMP Securities initiated coverage on ProQR Therapeutics N.V. (NASDAQ: PRQR) with a Market Outperform rating and a price target of $36.00.
For an analyst ratings summary and ratings history on ProQR Therapeutics N.V.... More
Leerink Swann Starts ProQR Therapeutics N.V. (PRQR) at Outperform
October 13, 2014 6:57 AM EDTLeerink Swann initiated coverage on ProQR Therapeutics N.V. (NASDAQ: PRQR) with an Outperform rating and a price target of $24.00.
For an analyst ratings summary and ratings history on ProQR Therapeutics N.V.... More
